Differences between breast cancers by ER/PR status have been shown in the aetiology [3,4,5,6,7,8,9,10,11], disease progression and prognosis [12], epidemiology [8,13,14,15] and response to available treatments [2,16,17]. The gene discussed is PGR; the disease is breast carcinoma.